Brief: Solara Active Pharma Updates On USFDA Test Results Of Ranitidine Samples
Nov 4 (Reuters) - Solara Active Pharma Sciences Ltd
SOLA.NS :
* USFDA RELEASES TESTING RESULTS OF RANITIDINE AND
NIZATIDINE
SAMPLES
* SOLARA ACTIVE PHARMA -MAJORITY OF MARKETED PRODUCTS IN US
THAT
WERE FOUND WITHIN ACCEPTABLE LIMITS WERE MANUFACTURED WITH APIS
SUPPLIED BY SOLARA
Source text for Eikon: ID:nBSE5Ff11Q
Further company coverage: SOLA.NS
(Reporting By Nallur Sethuraman in Bengaluru)
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees